Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities.
Clinical
Emerging executive functioning and motor development in infants at high and low risk for autism spectrum disorder.
Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial.
Greater pupil size in response to emotional faces as an early marker of social-communicative difficulties in infants at high risk for autism.
22q11.2 duplication syndrome: Elevated rate of autism spectrum disorder and need for medical screening.
Brain responses to biological motion predict treatment outcome in young children with autism.
Disruption of POGZ is associated with intellectual disability and autism spectrum disorders.
Keeping time in the brain: Autism spectrum disorder and audiovisual temporal processing.
Rett syndrome: Crossing the threshold to clinical translation.
Differential sensory fMRI signatures in autism and schizophrenia: Analysis of amplitude and trial-to-trial variability.
- Previous Page
- Viewing
- Next Page